No abstract available
Keywords:
MEPPC syndrome; SCN5A gene; flecainide; ventricular arrhythmias.
MeSH terms
-
Anti-Arrhythmia Agents / therapeutic use
-
Flecainide* / therapeutic use
-
Humans
-
Mutation / genetics
-
NAV1.5 Voltage-Gated Sodium Channel* / genetics
Substances
-
Flecainide
-
SCN5A protein, human
-
NAV1.5 Voltage-Gated Sodium Channel
-
Anti-Arrhythmia Agents